share_log

6-K: British American Tobacco p.l.c. 30 August 2024 Transation In Own Shares

6-K: British American Tobacco p.l.c. 30 August 2024 Transation In Own Shares

英美菸草公司於2024年8月30日轉讓自有股份
美股SEC公告 ·  08/30 09:28
Moomoo AI 已提取核心訊息
British American Tobacco (BAT), the global tobacco company, has filed a Form 6-K with the United States Securities and Exchange Commission (SEC) on August 30, 2024. The filing, which is a requirement for foreign private issuers in the US, includes a press release titled 'Transaction in own shares' dated the same day. The report indicates that BAT has engaged in a transaction involving its own shares, details of which were made public and available by the company. The document was signed by Nancy Jiang, Senior Assistant Company Secretary of British American Tobacco p.l.c. The address of BAT's principal executive office is Globe House, 4 Temple Place, London, United Kingdom.
British American Tobacco (BAT), the global tobacco company, has filed a Form 6-K with the United States Securities and Exchange Commission (SEC) on August 30, 2024. The filing, which is a requirement for foreign private issuers in the US, includes a press release titled 'Transaction in own shares' dated the same day. The report indicates that BAT has engaged in a transaction involving its own shares, details of which were made public and available by the company. The document was signed by Nancy Jiang, Senior Assistant Company Secretary of British American Tobacco p.l.c. The address of BAT's principal executive office is Globe House, 4 Temple Place, London, United Kingdom.
全球菸草公司英美菸草(BAT)已於2024年8月30日向美國證券交易委員會(SEC)提交6-k表格。該提交是美國外國私募股票發行人的要求,其中包括了同一天日期的題爲「交易所自購股份」的新聞發佈。報告指出,英美菸草已參與了一項涉及其自有股份的交易,相關細節已由該公司公開披露和提供。文件由英美菸草有限公司高級助理公司秘書Nancy Jiang簽署,並註明了BAT的總部地址位於英國倫敦泰晤士河畔廟宇地4號Globe House。
全球菸草公司英美菸草(BAT)已於2024年8月30日向美國證券交易委員會(SEC)提交6-k表格。該提交是美國外國私募股票發行人的要求,其中包括了同一天日期的題爲「交易所自購股份」的新聞發佈。報告指出,英美菸草已參與了一項涉及其自有股份的交易,相關細節已由該公司公開披露和提供。文件由英美菸草有限公司高級助理公司秘書Nancy Jiang簽署,並註明了BAT的總部地址位於英國倫敦泰晤士河畔廟宇地4號Globe House。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息